中文名 | BRD7552 |
英文名 | BRD7552 |
英文别名 | CS-1560 BRD7552 BRD-7552 BRD 7552 Methyl [2,3-O-bis(Benzo[1,3]dioxol-5-yl-carbamoyl)]-4-O-(4-ethoxycarbonyl-phenylcarbamoyl)-α-D-glucopyranoside α-D-Glucopyranoside, methyl, 2,3-bis(N-1,3-benzodioxol-5-ylcarbamate) 4-[N-[4-(ethoxycarbonyl)phenyl]carbamate] ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate |
CAS | 1137359-47-7 |
化学式 | C33H33N3O15 |
分子量 | 711.63 |
密度 | 1.53±0.1 g/cm3(Predicted) |
沸点 | 757.6±60.0 °C(Predicted) |
溶解度 | DMSO: ≥ 38 mg/mL |
酸度系数 | 11.81±0.20(Predicted) |
存储条件 | -20℃ |
体外研究 | BRD7552 (0-5 μM; 5 days) induces a dose-dependent increase in PDX1 protein levels after BRD7552 treatment in PANC-1 cells. BRD7552 acts in a FOXA2-dependent manner to increase PDX1 expression in human ductal cells. Nine-day treatment of PANC-1 cells with BRD7552 (0-10 μM) causes a dose-dependent increase in insulin mRNA expression. BRD7552 induces insulin expression in PANC-1 cells. BRD7552 increases H3 acetylation and H3K4me3 and decreases H3K9me3, results that are consistent with transcriptional activation of PDX1. The epigenetic changes induced by BRD7552 are consistent with transcriptional activation, and BRD7552 acts in a FOXA2-dependent manner. Western Blot Analysis Cell Line: PANC-1 cells Concentration: 1.25, 2.5, 5 μM Incubation Time: 5 days Result: Induced a dose-dependent increase in PDX1 protein levels. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.405 ml | 7.026 ml | 14.052 ml |
5 mM | 0.281 ml | 1.405 ml | 2.81 ml |
10 mM | 0.141 ml | 0.703 ml | 1.405 ml |
5 mM | 0.028 ml | 0.141 ml | 0.281 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!